44
Views
13
CrossRef citations to date
0
Altmetric
Original Research

Targeted regulation of MiR-98 on E2F1 increases chemosensitivity of leukemia cells K562/A02

, , &
Pages 3233-3239 | Published online: 29 Jun 2017

References

  • FerraraFSchifferCAAcute myeloid leukaemia in adultsLancet2013381986548449523399072
  • PatelJPGonenMFigueroaMEPrognostic relevance of integrated genetic profiling in acute myeloid leukemiaN Engl J Med2012366121079108922417203
  • TallmanMSGillilandDGRoweJMDrug therapy for acute myeloid leukemiaBlood200510641154116315870183
  • SorrentinoALiuCGAddarioAPeschleCScambiaGFerliniCRole of microRNAs in drug-resistant ovarian cancer cellsGynecol Oncol2008111347848618823650
  • EllisLMHicklinDJResistance to targeted therapies. Refining anticancer therapy in the era of molecular oncologyClin Cancer Res200915247471747820008847
  • LlaveCXieZKasschauKDCarringtonJCCleavage of Scarecrow-like mRNA targets directed by a class of Arabidopsis miRNAScience200229755892053205612242443
  • McManusMTMicroRNAs and cancerSemin Cancer Biol200313425325814563119
  • GregoryRIShiekhattarRMicroRNA biogenesis and cancerCancer Res20056593509351215867338
  • FanYHYeMHWuLOverexpression of miR-98 inhibits cell invasion in glioma cell lines via downregulation of IKKepsilonEur Rev Med Pharmacol Sci201519193593360426502849
  • ZhangSZhangCLiYWangPYueZXieSmiR-98 regulates cisplatin-induced A549 cell death by inhibiting TP53 pathwayBiomed Pharmacother201165643644221880462
  • ToKKZhanZLitmanTBatesSERegulation of ABCG2 expression at the 3′ untranslated region of its mRNA through modulation of transcript stability and protein translation by a putative microRNA in the S1 colon cancer cell lineMol Cell Biol200828175147516118573883
  • ZhuDXZhuWFangCmiR-181a/b significantly enhances drug sensitivity in chronic lymphocytic leukemia cells via targeting multiple anti-apoptosis genesCarcinogenesis20123371294130122610076
  • WendlerAKellerDAlbrechtCPelusoJJWehlingMInvolvement of let-7/miR-98 microRNAs in the regulation of progesterone receptor membrane component 1 expression in ovarian cancer cellsOncol Rep201125127327921109987
  • XiangQTangHYuJYinJYangXLeiXMicroRNA-98 sensitizes cisplatin-resistant human lung adenocarcinoma cells by up-regulation of HMGA2Pharmazie201368427428123700794
  • OgawaHIshiguroKGaubatzSLivingstonDMNakataniYA complex with chromatin modifiers that occupies E2F- and Myc-responsive genes in G0 cellsScience200229655701132113612004135
  • MaXGaoYFanYOverexpression of E2F1 promotes tumor malignancy and correlates with TNM stages in clear cell renal cell carcinomaPLoS One201389e7343624023875
  • Bhat-NakshatriPWangGCollinsNREstradiol-regulated microRNAs control estradiol response in breast cancer cellsNucleic Acids Res200937144850486119528081
  • ChenCRidzonDABroomerAJReal-time quantification of microRNAs by stem-loop RT-PCRNucleic Acids Res20053320e17916314309
  • LivakKJSchmittgenTDAnalysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) MethodMethods200125440240811846609
  • ChenSChenXXiuYLSunKXZongZHZhaoYmicroRNA 490–3P enhances the drug-resistance of human ovarian cancer cellsJ Ovarian Res201478425297343
  • YuPNYanMDLaiHCDownregulation of miR-29 contributes to cisplatin resistance of ovarian cancer cellsInt J Cancer2014134354255123904094
  • HeXXiaoXDongLMiR-218 regulates cisplatin chemosensitivity in breast cancer by targeting BRCA1Tumour Biol20153632065207525394901
  • KovesdiIReichelRNevinsJRE1A transcription induction: enhanced binding of a factor to upstream promoter sequencesScience198623147397197222935935
  • EngelmannDPutzerBMThe dark side of E2F1: in transit beyond apoptosisCancer Res201272357157522298593
  • EngelmannDPutzerBMTranslating DNA damage into cancer cell death-A roadmap for E2F1 apoptotic signalling and opportunities for new drug combinations to overcome chemoresistanceDrug Resist Updat2010134–511913120675184
  • LouieMCZouJXRabinovichAChenHWACTR/AIB1 functions as an E2F1 coactivator to promote breast cancer cell proliferation and antiestrogen resistanceMol Cell Biol200424125157517115169882
  • AndersenJBFactorVMMarquardtJUAn integrated genomic and epigenomic approach predicts therapeutic response to zebularine in human liver cancerSci Transl Med201025454ra77
  • YoshiharaYWuDKuboNSangMNakagawaraAOzakiTInhibitory role of E2F-1 in the regulation of tumor suppressor p53 during DNA damage responseBiochem Biophys Res Commun20124211576322480684
  • RosenfeldtMTBellLALongJSE2F1 drives chemotherapeutic drug resistance via ABCG2Oncogene201433324164417224276245
  • SiragamVRutnamZJYangWMicroRNA miR-98 inhibits tumor angiogenesis and invasion by targeting activin receptor-like kinase-4 and matrix metalloproteinase-11Oncotarget20123111370138523211491
  • HuangSDYuanYZhuangCWMicroRNA-98 and microRNA-214 post-transcriptionally regulate enhancer of zeste homolog 2 and inhibit migration and invasion in human esophageal squamous cell carcinomaMol Cancer2012115122867052
  • Griffiths-JonesSSainiHKvan DongenSEnrightAJmiRBase: tools for microRNA genomicsNucleic Acids Res200836D154D15817991681
  • HebertCNorrisKScheperMANikitakisNSaukJJHigh mobility group A2 is a target for miRNA-98 in head and neck squamous cell carcinomaMol Cancer20076517222355
  • SampsonVBRongNHHanJMicroRNA let-7a down-regulates MYC and reverts MYC-induced growth in Burkitt lymphoma cellsCancer Res200767209762977017942906
  • GennarinoVASardielloMAvellinoRMicroRNA target prediction by expression analysis of host genesGenome Res200919348149019088304